Submission Details
| 510(k) Number | K935702 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | November 30, 1993 |
| Decision Date | November 22, 1994 |
| Days to Decision | 357 days |
| Submission Type | Traditional |
| Review Panel | Hematology (HE) |
| Summary | Summary PDF |
K935702 is an FDA 510(k) clearance for the DADE INNOVIN II, a Test, Time, Prothrombin (Class II — Special Controls, product code GJS), submitted by Baxter Diagnostics, Inc. (Mcgaw Park, US). The FDA issued a Cleared decision on November 22, 1994, 357 days after receiving the submission on November 30, 1993. This device falls under the Hematology review panel. Regulated under 21 CFR 864.7750.
| 510(k) Number | K935702 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | November 30, 1993 |
| Decision Date | November 22, 1994 |
| Days to Decision | 357 days |
| Submission Type | Traditional |
| Review Panel | Hematology (HE) |
| Summary | Summary PDF |
| Product Code | GJS — Test, Time, Prothrombin |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 864.7750 |